Financials
Financial year 2025
MEDIFA from Gent, company number BE0785526685, closed financial year 2025 with a result of € 887,436 after tax. For that financial year MEDIFA recorded a gross margin of € 664,550 and equity of € 3.4 million. Compared with financial year 2024, the result moved from € 785,517 to € 887,436. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 16, 2026.
€ 3.4 million
▲ 27% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 887,436
▲ 13% vs 2024
Profit after tax over the fiscal year.
€ 37,130
▲ 20% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 165,000 paid out
19 % of the profit went to the shareholders, the rest stayed in the company.
People and assets in 2025
€ 3,013
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 1.3 million
▼ 22% vs 2024
€ 368,700 is repaid this year. At this pace the long-term loan is gone in ≈ 4 years.
€ 252,250
▲ € 209,914 vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 102,669
▼ 46% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
| 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|
| Gross margin | € 101,658 | € 621,128 | € 664,550 | ▲ 7% |
| Profit after taxes | € 11,308 | € 785,517 | € 887,436 | ▲ 13% |
| Equity | € 2,004,559 | € 2,665,963 | € 3,388,399 | ▲ 27% |
| Total debts | € 2,198,017 | € 2,045,596 | € 1,848,744 | ▼ 10% |
| Cash | € 10,240 | € 30,921 | € 37,130 | ▲ 20% |
| Retained profit | € 11,308 | € 672,711 | € 1,395,148 | ▲ 107% |
| Dividend | € 0 | € 124,114 | € 165,000 | ▲ 33% |
| Bank debt | € 2,089,275 | € 1,689,850 | € 1,321,150 | ▼ 22% |
| Balance sheet total | € 4,202,576 | € 4,711,559 | € 5,237,143 | ▲ 11% |
Key figures of MEDIFA, fiscal years 2023 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to MEDIFA?
What happened at MEDIFA in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 887,436 (▲ 13% vs 2024). Source: NBB ↗
- Capital increase published in the Gazette. Source: Staatsblad ↗
- Incorporation, published in the Gazette. Source: Staatsblad ↗
- New establishment in Gent. KBO
- Skinmedicon BV became a director. NBB
In short
From € 11,308 profit in 2023 to € 887,436 profit in 2025.
Paid € 372,636 in corporate taxes since 2023.
Best year ever: 2025, with € 887,436 profit.
Paid out € 289,114 in dividends to the owners in total.
Management
Behind MEDIFA is Skinmedicon BV. It owns 100% of Intramedics, 100% of Art Medico Clinic and 100% of Emmagenics itself.
Directors
According to the 2025 annual accounts
Director · represented by Farah Bourakadi
since 2022
Establishments
Establishment units
Physical locations of this company
Kortrijksesteenweg 1202 box B/C
9051 Gent
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 5 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Website
Technologies
Certifications & Partners
Hosting & Email
Email provider
Microsoft 365
Hosting
COMBELL-AS, BE
Website info
Features
Security
Network
Shareholders according to the Official Gazette deeds
Who contributed at incorporation and at capital increases, with the deed as source. Later share transfers are not published in the Gazette.
Capital increase
Source: Deed ↗- BOURAKADI Farah(inbrenger)
Incorporation
Source: Deed ↗- BOURAKADI, Farah(oprichter) 100%
Details
- Company number
- 0785.526.685
- VAT number
- BE 0785.526.685
- Registered office
- Kortrijksesteenweg 1202 bus B/C, 9051 Gent
- Names & denominations
- MEDIFA
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 28 April 2022
- Peppol
- Active · Active since 1 Sept 2025
- Contact
- art-medico.be
- Activities · NACE
Activiteiten van holdings
Holdings
Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies
Overige zakelijke dienstverlening, neg
Overige adviesbureaus op het gebied van bedrijfsbeheer; adviesbureaus op het gebied van bedrijfsvoering